Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice

Michelle Schorer, Karim Debache, Fabienne Barna, Thierry Monney, Joachim Müller, David W. Boykin, Chad E. Stephens, Andrew Hemphill

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Neospora caninum is considered to be the main cause of bovine abortion in Europe and the USA, leading to considerable financial impact. Losses are caused directly by abortions or indirectly through breeding of calves with impaired viability. Due to the lack of effective chemotherapy against bovine neosporosis, there is a need to develop new anti-protozoal compounds, which would either eliminate the parasite or avoid its transmission. In order to identify compounds of interest, the in vitro activities of 41 di-cationic pentamidine derivatives were studied employing a transgenic N. caninum clone expressing beta-galactosidase as a reporter gene. The arylimidamide DB745, previously shown to be highly active against Leishmania donovani in vitro and in vivo, appeared as the most promising compound, with an IC 50 of 80nM in 3-day growth assays and severely affecting both host cell invasion as well as intracellular proliferation. TEM of intracellular tachyzoites identified distinct alterations related to the nucleolus and the nuclear and cellular membrane. Long-term growth assays showed that DB745 acted parasiticidal upon the Nc-Liv isolate, but not against the Nc-1 isolate of N. caninum. In vivo studies in N. caninum (Nc-1 isolate) infected mice showed that daily intraperitoneal application of DB745 for a period of 14days resulted in a decreased number of clinically affected animals, and lower cerebral parasite burdens in DB745-treated mice compared to non-treated mice. These results illustrate the potential of dicationic arylimidamides for the treatment of N. caninum infections.

Original languageEnglish (US)
Pages (from-to)109-120
Number of pages12
JournalInternational Journal for Parasitology: Drugs and Drug Resistance
Volume2
DOIs
StatePublished - Dec 1 2012

Fingerprint

Neospora
Membranes
Infection
Parasites
Pentamidine
Leishmania donovani
Nuclear Envelope
beta-Galactosidase
Growth
Reporter Genes
Breeding
Clone Cells
Drug Therapy

Keywords

  • Arylimidamides
  • In vivo activity
  • Invasion
  • Membrane integrity
  • Neospora caninum
  • Nucleolus
  • Proliferation
  • Tachyzoites

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice. / Schorer, Michelle; Debache, Karim; Barna, Fabienne; Monney, Thierry; Müller, Joachim; Boykin, David W.; Stephens, Chad E.; Hemphill, Andrew.

In: International Journal for Parasitology: Drugs and Drug Resistance, Vol. 2, 01.12.2012, p. 109-120.

Research output: Contribution to journalArticle

@article{718c4014af5845c5b7bd457783a26606,
title = "Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice",
abstract = "Neospora caninum is considered to be the main cause of bovine abortion in Europe and the USA, leading to considerable financial impact. Losses are caused directly by abortions or indirectly through breeding of calves with impaired viability. Due to the lack of effective chemotherapy against bovine neosporosis, there is a need to develop new anti-protozoal compounds, which would either eliminate the parasite or avoid its transmission. In order to identify compounds of interest, the in vitro activities of 41 di-cationic pentamidine derivatives were studied employing a transgenic N. caninum clone expressing beta-galactosidase as a reporter gene. The arylimidamide DB745, previously shown to be highly active against Leishmania donovani in vitro and in vivo, appeared as the most promising compound, with an IC 50 of 80nM in 3-day growth assays and severely affecting both host cell invasion as well as intracellular proliferation. TEM of intracellular tachyzoites identified distinct alterations related to the nucleolus and the nuclear and cellular membrane. Long-term growth assays showed that DB745 acted parasiticidal upon the Nc-Liv isolate, but not against the Nc-1 isolate of N. caninum. In vivo studies in N. caninum (Nc-1 isolate) infected mice showed that daily intraperitoneal application of DB745 for a period of 14days resulted in a decreased number of clinically affected animals, and lower cerebral parasite burdens in DB745-treated mice compared to non-treated mice. These results illustrate the potential of dicationic arylimidamides for the treatment of N. caninum infections.",
keywords = "Arylimidamides, In vivo activity, Invasion, Membrane integrity, Neospora caninum, Nucleolus, Proliferation, Tachyzoites",
author = "Michelle Schorer and Karim Debache and Fabienne Barna and Thierry Monney and Joachim M{\"u}ller and Boykin, {David W.} and Stephens, {Chad E.} and Andrew Hemphill",
year = "2012",
month = "12",
day = "1",
doi = "10.1016/j.ijpddr.2012.03.001",
language = "English (US)",
volume = "2",
pages = "109--120",
journal = "International Journal for Parasitology: Drugs and Drug Resistance",
issn = "2211-3207",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice

AU - Schorer, Michelle

AU - Debache, Karim

AU - Barna, Fabienne

AU - Monney, Thierry

AU - Müller, Joachim

AU - Boykin, David W.

AU - Stephens, Chad E.

AU - Hemphill, Andrew

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Neospora caninum is considered to be the main cause of bovine abortion in Europe and the USA, leading to considerable financial impact. Losses are caused directly by abortions or indirectly through breeding of calves with impaired viability. Due to the lack of effective chemotherapy against bovine neosporosis, there is a need to develop new anti-protozoal compounds, which would either eliminate the parasite or avoid its transmission. In order to identify compounds of interest, the in vitro activities of 41 di-cationic pentamidine derivatives were studied employing a transgenic N. caninum clone expressing beta-galactosidase as a reporter gene. The arylimidamide DB745, previously shown to be highly active against Leishmania donovani in vitro and in vivo, appeared as the most promising compound, with an IC 50 of 80nM in 3-day growth assays and severely affecting both host cell invasion as well as intracellular proliferation. TEM of intracellular tachyzoites identified distinct alterations related to the nucleolus and the nuclear and cellular membrane. Long-term growth assays showed that DB745 acted parasiticidal upon the Nc-Liv isolate, but not against the Nc-1 isolate of N. caninum. In vivo studies in N. caninum (Nc-1 isolate) infected mice showed that daily intraperitoneal application of DB745 for a period of 14days resulted in a decreased number of clinically affected animals, and lower cerebral parasite burdens in DB745-treated mice compared to non-treated mice. These results illustrate the potential of dicationic arylimidamides for the treatment of N. caninum infections.

AB - Neospora caninum is considered to be the main cause of bovine abortion in Europe and the USA, leading to considerable financial impact. Losses are caused directly by abortions or indirectly through breeding of calves with impaired viability. Due to the lack of effective chemotherapy against bovine neosporosis, there is a need to develop new anti-protozoal compounds, which would either eliminate the parasite or avoid its transmission. In order to identify compounds of interest, the in vitro activities of 41 di-cationic pentamidine derivatives were studied employing a transgenic N. caninum clone expressing beta-galactosidase as a reporter gene. The arylimidamide DB745, previously shown to be highly active against Leishmania donovani in vitro and in vivo, appeared as the most promising compound, with an IC 50 of 80nM in 3-day growth assays and severely affecting both host cell invasion as well as intracellular proliferation. TEM of intracellular tachyzoites identified distinct alterations related to the nucleolus and the nuclear and cellular membrane. Long-term growth assays showed that DB745 acted parasiticidal upon the Nc-Liv isolate, but not against the Nc-1 isolate of N. caninum. In vivo studies in N. caninum (Nc-1 isolate) infected mice showed that daily intraperitoneal application of DB745 for a period of 14days resulted in a decreased number of clinically affected animals, and lower cerebral parasite burdens in DB745-treated mice compared to non-treated mice. These results illustrate the potential of dicationic arylimidamides for the treatment of N. caninum infections.

KW - Arylimidamides

KW - In vivo activity

KW - Invasion

KW - Membrane integrity

KW - Neospora caninum

KW - Nucleolus

KW - Proliferation

KW - Tachyzoites

UR - http://www.scopus.com/inward/record.url?scp=84861467332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861467332&partnerID=8YFLogxK

U2 - 10.1016/j.ijpddr.2012.03.001

DO - 10.1016/j.ijpddr.2012.03.001

M3 - Article

AN - SCOPUS:84861467332

VL - 2

SP - 109

EP - 120

JO - International Journal for Parasitology: Drugs and Drug Resistance

JF - International Journal for Parasitology: Drugs and Drug Resistance

SN - 2211-3207

ER -